Results 61 to 70 of about 3,448,602 (316)

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm   +10 more
wiley   +1 more source

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost   +10 more
wiley   +1 more source

SYSTEM TRANSFORMATION OF THE AGRICULTURE ENTERPRISES WITHIN DIGITALIZATION OF MARKET RELATIONS

open access: yesИзвестия высших учебных заведений. Поволжский регион: Общественные науки, 2020
Background. The relevance of the article’s topic is due to the fact that, thanks to the use of digital technologies, there is a significant increase in the efficiency of various types of production in the branches of the agro-industrial complex (AIC ...
V. M. Volodin, N. A. Nad'kina
doaj   +1 more source

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender   +17 more
wiley   +1 more source

INCREASING THE INVESTMENT ATTRACTIVENESS OF THE AGRICULTURAL SECTOR IN RUSSIA

open access: yesФинансы: теория и практика, 2018
The article studies the management system of investment attractiveness in the agricultural sector. The authors set the task of analytical (evaluation of investment attractiveness of the Russian agricultural sector using economicmathematical and economic ...
V. A. Tsvetkov   +3 more
doaj   +1 more source

Perception study of state support programs for companies, in Talca, Chile in times of Covid 19. [PDF]

open access: yesPLoS One, 2022
Bustamante-Ubilla M   +4 more
europepmc   +1 more source

Improving the Evaluation and Management of Transfusion‐Related Iron Overload in Children, Adolescents, and Young Adults Following Cancer Treatment or Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Transfusion‐related iron overload (TRIO) is a late effect of therapy impacting survivors of childhood cancer and hematopoietic stem cell transplantation (HSCT) who receive frequent packed red blood cell (pRBC) transfusions. Surprisingly, there are no accepted guidelines to assist providers in identifying and treating at‐risk ...
Luke Gingell   +3 more
wiley   +1 more source

THE INFLUENCE OF SOCIO-ECONOMIC FACTORS ON THE DEVELOPMENT OF RESIDENTIAL MORTGAGE LENDING (CASE STUDY OF THE ALTAI TERRITORY)

open access: yesФинансы: теория и практика, 2017
Nowadays the residential mortgage lending is a matter of great importance for the socio-economic development of Russia in the context of providing the majority of people with owner-occupied homes.
N. I. Glotova, T. E. Fasenko
doaj   +1 more source

Home - About - Disclaimer - Privacy